These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 19797701)

  • 1. US geographic distribution of rt-PA utilization by hospital for acute ischemic stroke.
    Kleindorfer D; Xu Y; Moomaw CJ; Khatri P; Adeoye O; Hornung R
    Stroke; 2009 Nov; 40(11):3580-4. PubMed ID: 19797701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. National US estimates of recombinant tissue plasminogen activator use: ICD-9 codes substantially underestimate.
    Kleindorfer D; Lindsell CJ; Brass L; Koroshetz W; Broderick JP
    Stroke; 2008 Mar; 39(3):924-8. PubMed ID: 18239184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant tissue plasminogen activator (rt-PA) utilisation by rural clinicians in acute ischaemic stroke: an audit of current practice and clinical outcomes.
    Williams JM; Navin TJ; Jude MR; Levi CR
    Aust J Rural Health; 2013 Aug; 21(4):203-7. PubMed ID: 24033520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors associated with the administration of tissue plasminogen activator for acute ischemic stroke.
    Kunisawa S; Kobayashi D; Lee J; Otsubo T; Ikai H; Yokota C; Minematsu K; Imanaka Y
    J Stroke Cerebrovasc Dis; 2014 Apr; 23(4):724-31. PubMed ID: 23910512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sex differences in the use of intravenous rt-PA thrombolysis treatment for acute ischemic stroke: a meta-analysis.
    Reeves M; Bhatt A; Jajou P; Brown M; Lisabeth L
    Stroke; 2009 May; 40(5):1743-9. PubMed ID: 19228855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is there a decreased risk of intracerebral hemorrhage and mortality in obese patients treated with intravenous thrombolysis in acute ischemic stroke?
    Hassan AE; Chaudhry SA; Jani V; Grigoryan M; Khan AA; Adil MM; Qureshi AI
    J Stroke Cerebrovasc Dis; 2013 May; 22(4):545-9. PubMed ID: 23453555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utilization of intravenous thrombolysis in 3-4.5 hours: analysis of the Minnesota stroke registry.
    Tekle WG; Chaudhry SA; Hassan AE; Peacock JM; Lakshminarayan K; Tsai A; Luepker R; Anderson DC; Qureshi AI
    Cerebrovasc Dis; 2012; 34(5-6):400-5. PubMed ID: 23221276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of thrombolysis with recombinant tissue plasminogen activator for acute ischemic stroke assessed by a model based on UK NHS costs.
    Sandercock P; Berge E; Dennis M; Forbes J; Hand P; Kwan J; Lewis S; Lindley R; Neilson A; Wardlaw J
    Stroke; 2004 Jun; 35(6):1490-7. PubMed ID: 15105519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue plasminogen activator (rt-PA) in acute ischemic stroke: Outcomes associated with ambulation.
    Lawson TR; Brown IE; Westerkam DL; Blackhurst DW; Sternberg S; Leacock R; Nathaniel TI
    Restor Neurol Neurosci; 2015; 33(3):301-8. PubMed ID: 25698111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accuracy of the new ICD-9-CM code for "drip-and-ship" thrombolytic treatment in patients with ischemic stroke.
    Tonarelli SB; Tibbs M; Vazquez G; Lakshminarayan K; Rodriguez GJ; Qureshi AI
    J Stroke Cerebrovasc Dis; 2012 Feb; 21(2):121-3. PubMed ID: 20851622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A pharmacoeconomic assessment of recombinant tissue plasminogen activator therapy for acute ischemic stroke in a tertiary hospital in China.
    Yan X; Hu HT; Liu S; Sun YH; Gao X
    Neurol Res; 2015 Apr; 37(4):352-8. PubMed ID: 25297471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic thrombolytic therapy in acute ischemic stroke--new experiences in spreading network of stroke units in Croatia.
    Matijević V; Poljaković Z; Malojčić B; Mišmaš A; Bazina A; Boban M; Bilić I; Radanović B; Glavor KD; Kiđemet-Piskač S; Habek M
    J Neurol Sci; 2012 Mar; 314(1-2):126-9. PubMed ID: 22063080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. United States trends in thrombolysis for older adults with acute ischemic stroke.
    George BP; Asemota AO; Dorsey ER; Haider AH; Smart BJ; Urrutia VC; Schneider EB
    Clin Neurol Neurosurg; 2015 Dec; 139():16-23. PubMed ID: 26363362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use and in-hospital outcomes of recombinant tissue plasminogen activator in pediatric arterial ischemic stroke patients.
    Nasr DM; Biller J; Rabinstein AA
    Pediatr Neurol; 2014 Nov; 51(5):624-31. PubMed ID: 25194722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety of full-dose intravenous recombinant tissue plasminogen activator followed by multimodal endovascular therapy for acute ischemic stroke.
    Nogueira RG; Yoo AJ; Masrur S; Batista LM; Hakimelahi R; Hirsch JA; Schwamm LH
    J Neurointerv Surg; 2013 Jul; 5(4):298-301. PubMed ID: 22705875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adherence to guidelines by emergency medical services during transport of stroke patients receiving intravenous thrombolytic infusion.
    Asaithambi G; Chaudhry SA; Hassan AE; Rodriguez GJ; Suri MF; Qureshi AI
    J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):e42-5. PubMed ID: 22572162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous thrombolysis for acute ischemic stroke--our experiences.
    Antoncić I; Dunatov S; Bralić M; Perković O; Coklo M; Jurjević A
    Coll Antropol; 2011 Jun; 35(2):483-6. PubMed ID: 21755722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of intravenous recombinant tissue plasminogen activator in acute ischemic stroke.
    Kahn JH; Viereck J; Kase C; Jeerakathil T; Romero R; Mehta SD; Kociol R; Babikian V
    J Emerg Med; 2005 Oct; 29(3):273-7. PubMed ID: 16183445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increasing number of stroke specialists should contribute to utilization of IV rt-PA: results of questionnaires from 1,466 hospitals in Japan.
    Iguchi Y; Kimura K; Shibazaki K; Iwanaga T
    J Neurol Sci; 2009 Apr; 279(1-2):66-9. PubMed ID: 19185882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do centres with well-developed protocols, training and infrastructure have higher rates of thrombolysis for acute ischaemic stroke?
    van Wijngaarden JD; Dirks M; Niessen LW; Huijsman R; Dippel DW
    QJM; 2011 Sep; 104(9):785-91. PubMed ID: 21613273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.